Literature DB >> 30830241

Abnormalities in chemokine receptor recycling in chronic lymphocytic leukemia.

Laura Patrussi1, Nagaja Capitani2, Cosima T Baldari2.   

Abstract

In addition to their modulation through de novo expression and degradation, surface levels of chemokine receptors are tuned by their ligand-dependent recycling to the plasma membrane, which ensures that engaged receptors become rapidly available for further rounds of signaling. Dysregulation of this process contributes to the pathogenesis of chronic lymphocytic leukemia (CLL) by enhancing surface expression of chemokine receptors, thereby favoring leukemic cell accumulation in the protective niche of lymphoid organs. In this review, we summarize our current understanding of the process of chemokine receptor recycling, focusing on the impact of its dysregulation in CLL.

Entities:  

Keywords:  CLL; Chemokine receptor; Desensitization; Recycling; Resensitization

Mesh:

Substances:

Year:  2019        PMID: 30830241     DOI: 10.1007/s00018-019-03058-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  5 in total

1.  p66Shc Deficiency in Chronic Lymphocytic Leukemia Promotes Chemokine Receptor Expression Through the ROS-Dependent Inhibition of NF-κB.

Authors:  Vanessa Tatangelo; Gioia Boncompagni; Nagaja Capitani; Ludovica Lopresti; Noemi Manganaro; Federica Frezzato; Andrea Visentin; Livio Trentin; Cosima T Baldari; Laura Patrussi
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

Review 2.  P66Shc: A Pleiotropic Regulator of B Cell Trafficking and a Gatekeeper in Chronic Lymphocytic Leukemia.

Authors:  Laura Patrussi; Nagaja Capitani; Cosima T Baldari
Journal:  Cancers (Basel)       Date:  2020-04-19       Impact factor: 6.639

3.  Optimization of Organotypic Cultures of Mouse Spleen for Staining and Functional Assays.

Authors:  Francesca Finetti; Nagaja Capitani; Noemi Manganaro; Vanessa Tatangelo; Francesca Libonati; Giulia Panattoni; Ivo Calaresu; Laura Ballerini; Cosima T Baldari; Laura Patrussi
Journal:  Front Immunol       Date:  2020-03-24       Impact factor: 7.561

4.  Modeling the Antileukemia Activity of Ellipticine-Related Compounds: QSAR and Molecular Docking Study.

Authors:  Edgar Márquez; José R Mora; Virginia Flores-Morales; Daniel Insuasty; Luis Calle
Journal:  Molecules       Date:  2019-12-19       Impact factor: 4.411

Review 5.  Interleukin (IL)-9 Supports the Tumor-Promoting Environment of Chronic Lymphocytic Leukemia.

Authors:  Laura Patrussi; Nagaja Capitani; Cosima T Baldari
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.